Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer

This publication has 42 references indexed in Scilit:

• Levonorgestrel‐impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial
  BJOG: An International Journal of Obstetrics & Gynaecology, 2013
• Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
  Gynecologic Oncology, 2012
• Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature
  Gynecologic Oncology, 2012
• Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis
  American Journal of Obstetrics and Gynecology, 2010
• Progestogen treatment options for early endometrial cancer
  BJOG: An International Journal of Obstetrics & Gynaecology, 2010
• Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship
  Gynecologic Oncology, 2009
• Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women
  Journal of Clinical Oncology, 2007
• Fertility‐preserving treatment in young patients with endometrial adenocarcinoma
  Cancer, 2002
• Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40
  Obstetrics & Gynecology, 1997
• TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD
  Clinical Endocrinology, 1982